SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Mar 7, 2017

InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: March 7, 2017 · CIK: 0001433607 · Accession: 0001493152-17-002193

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-215682

Date
January 24, 2017
Author
Dawson
Form
CORRESP
Company
InspireMD, Inc. (NSPR) (CIK 0001433607)

Letter

March 7, 2017

VIA EDGAR

United States Securities and Exchange Commission

F Street, NE

Washington, D.C. 20549Attention:

Ms. Heather Percival

Mr. Geoff Kruczek

Ms. Amanda Ravitz

Re: InspireMD, Inc.

Registration Statement on Form S-1, originally filed on January 24, 2017

File No. 333-215682, as amended (the “Registration Statement”)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as underwriter of the proposed offering, hereby joins the request of InspireMD, Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared effective at 4:00 p.m. (Washington, D.C. time) on March 8, 2017, or as soon as practicable thereafter.

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise you that we have effected the distribution of 344 copies to institutions and individuals of the Company’s preliminary prospectus dated March 6, 2017 through the date hereof.

We have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Sincerely,
Dawson
James Securities, Inc.

Show Raw Text
CORRESP
1
filename1.htm

March
7, 2017

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, NE

Washington,
D.C. 20549Attention:

    Ms.
    Heather Percival

    Mr.
    Geoff Kruczek

    Ms.
    Amanda Ravitz

    Re:
    InspireMD,
    Inc.

    Registration
    Statement on Form S-1, originally filed on January 24, 2017

    File
    No. 333-215682, as amended (the “Registration Statement”)

    Request
    for Acceleration

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as underwriter of the proposed offering, hereby joins
the request of InspireMD, Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared
effective at 4:00 p.m. (Washington, D.C. time) on March 8, 2017, or as soon as practicable thereafter.

Pursuant
to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise you that we have
effected the distribution of 344 copies to institutions and individuals of the Company’s preliminary prospectus dated March
6, 2017 through the date hereof.

We
have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

    Sincerely,

    Dawson
    James Securities, Inc.

    By:
    /s/
    Thomas W. Hands

    Name:
    Thomas
    W. Hands

    Title:
    President